ESPERANZA: External Control Arm Study for T-DXd for Patients With HER2 IHC3+ Solid Tumors
AstraZeneca
AstraZeneca
Origin Sciences
National Institutes of Health Clinical Center (CC)
UMC Utrecht
AstraZeneca
Alliance for Clinical Trials in Oncology
University of Nebraska
Adela, Inc
Imperial College London
Elephas
Elephas
City of Hope Medical Center
Washington University School of Medicine
Travera Inc
Guardant Health, Inc.
Tempus AI
Arbeitsgemeinschaft medikamentoese Tumortherapie
Royal Marsden NHS Foundation Trust
Singlera Genomics Inc.
Travera Inc
Fondazione Policlinico Universitario Agostino Gemelli IRCCS
UNC Lineberger Comprehensive Cancer Center
DxTerity Diagnostics
Cancer Support Community, Research and Training Institute, Philadelphia
Charite University, Berlin, Germany
University of California, Davis
Memorial Sloan Kettering Cancer Center
Wuhan Ammunition Life-tech Co., Ltd
Exact Sciences Corporation
Assistance Publique - Hôpitaux de Paris
TScan Therapeutics, Inc.
University of Pennsylvania
SpeciCare
Gary Onik MD
M.D. Anderson Cancer Center
Swiss Cancer Institute
CureOne
Quantgene Inc.
GlaxoSmithKline
Wake Forest University Health Sciences
Università degli Studi 'G. d'Annunzio' Chieti e Pescara
Amgen
M.D. Anderson Cancer Center
OHSU Knight Cancer Institute
National Cancer Institute (NCI)
Meir Medical Center